Carregant...
Letter to the editor, Reply to: Lee and Matulonis: Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
• CALLA (NCT03830866) is a randomized, international, double-blind, placebo-controlled study. • Immunotherapy-naïve patients with adenocarcinoma or cervical carcinoma are being enrolled. • CALLA is one of the largest trials in this patient population.
Guardat en:
| Publicat a: | Gynecol Oncol Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6906726/ https://ncbi.nlm.nih.gov/pubmed/31867430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2019.100506 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|